Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Clinical Outcomes Of Primary Sclerosing Cholangitis In North America
Sclerosing cholangitis
All genders
No minimum age
Recruiting now
Department of Medicine, Division of Gastroenterology + Hepatology